zSpace and Labtech Introduce Heavy Vehicle Fundamentals to Strengthen Diesel & Transportation Career Pathways with Immersive AR Learning
Globenewswire· 2025-12-18 13:00
Application brings diesel and heavy vehicle systems training to classrooms and workforce programsSAN JOSE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a leader in immersive augmented reality (AR) learning solutions, today announced the launch of Heavy Vehicle Fundamentals by Labtech, a comprehensive AR-powered training solution designed to help students build foundational knowledge and hands-on skills in diesel, trucking, and heavy vehicle systems. Developed in collaboration with ...
Icon Energy Corp. Announces Share Repurchase Program
Globenewswire· 2025-12-18 13:00
ATHENS, Greece, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Icon Energy Corp. (“Icon” or the “Company”) (Nasdaq: ICON), an international shipping company providing worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels, announced today that its Board of Directors has authorized a program under which the Company may, from time to time, repurchase up to an aggregate of $1.0 million of its outstanding common shares through December 31, 2026 (the “Program”). Repurchases of com ...
Rezolve Ai Warns Generic LLM Chatbots Are Embarrassing Global Brands After The Gap, Inc. Incident
Globenewswire· 2025-12-18 13:00
Independent reporting exposes enterprise chatbots discussing sex toys, magic mushrooms, and Nazis, underscoring why generic, hallucination-prone LLMs are unfit for live commerceNEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV) (the “Company” or “Rezolve Ai”), a leader in Agentic Commerce and AI-powered customer engagement, today highlighted recent independent reporting that underscores what the Company believes is an escalating and very public problem for the AI industry: enterprise chat ...
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
Globenewswire· 2025-12-18 13:00
Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral gastroenteritis caused by norovirus infectionThere are no approved treatments or vaccines currently available for norovirus infection BOTHELL, Wash., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces the approval from the Institutional Review Board (IRB) at E ...
Federal Signal to Acquire Mega Corp.; Expand Specialty Metal Extraction Support Equipment Vertical
Prnewswire· 2025-12-18 13:00
DOWNERS GROVE, Ill., Dec. 18, 2025 /PRNewswire/ -- Federal Signal Corporation (NYSE: FSS) (the "Company" or "Federal Signal"), a leader in environmental and safety solutions, today announced the signing of a definitive agreement to acquire Mega Corp. ("Mega"), a leading manufacturer of specialty vehicles and equipment for use in global metal extraction and construction markets, for cash consideration of $45.5 million, subject to post-closing adjustments. The purchase price includes the acquisition of Mega' ...
The Blueprint To Navigate Option ETFs Through 2026
Seeking Alpha· 2025-12-18 13:00
Core Viewpoint - The market is expected to be driven by the expansion of technology, particularly for the S&P 500 in 2026 [1] Investment Strategy - A hybrid investment strategy combining classic dividend growth stocks, Business Development Companies, REITs, and Closed End Funds can enhance investment income while achieving total returns comparable to traditional index funds [1]
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
Globenewswire· 2025-12-18 13:00
OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral direct activator, OV4071There were no treatment-related laboratory findings, no safety findings, and no treatment-related serious adverse events (SAEs)Exploratory quantitative electrophysiology results suggest OV350 had central activity and spectral power consistent with expected physiological effects of KCC2 modulation; aligned with expected drug exposure in the brainPharmacokinetics for ...
HBT Financial, Inc. Announces Authorization of New $30 Million Stock Repurchase Program
Globenewswire· 2025-12-18 13:00
BLOOMINGTON, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) -- HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”) announced today that its Board of Directors has approved a new stock repurchase program (the “Program”) that takes effect upon the expiration of the Company’s current stock repurchase program on January 1, 2026. The Company will not execute additional repurchases under the current program after January 1, 2026. The new Program authorizes the Company to repurchase up to $30 million of its ...
Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma
Prnewswire· 2025-12-18 13:00
2i2 The approval is supported by findings from the MEMBRANE randomized controlled trial, which evaluated the safety and effectiveness of MMA embolization in patients with cSDH. The results of the MEMBRANE study demonstrated that TRUFILL n-BCA is superior in effectiveness compared to Standard of Care (SOC) for embolization in the MMA for the treatment of symptomatic cSDH, and importantly, TRUFILL n-BCA was demonstrated to be safe for treating cSDH. "This approval reinforces the enduring value of TRUFILL n-BC ...
DIRTT Announces Renewal of Normal Course Issuer Bid for Common Shares
Globenewswire· 2025-12-18 13:00
CALGARY, Alberta, Dec. 18, 2025 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (TSX: DRT; OTCQX: DRTTF) ("DIRTT" or the "Company"), a leader in industrialized construction, announced today that the Toronto Stock Exchange ("TSX") has accepted DIRTT's notice of intention to renew its normal course issuer bid (the "Renewed NCIB") for common shares in the capital of DIRTT ("Common Shares"). The Renewed NCIB is expected to commence on December 22, 2025, following the expiry of the Company's current NCIB ...